Page last updated: 2024-11-10

chrysoeriol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chrysoeriol: isolated from leaves of Eurya japonica & E. emarginata [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4',5,7-trihydroxy-3'-methoxyflavone : The 3'-O-methyl derivative of luteolin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Euryagenus[no description available]Pentaphylacaceae[no description available]
Eurya japonicaspecies[no description available]Pentaphylacaceae[no description available]

Cross-References

ID SourceID
PubMed CID5280666
CHEMBL ID214321
CHEBI ID16514
SCHEMBL ID293757
MeSH IDM0049985

Synonyms (66)

Synonym
4',5,7-trihydroxy-3'-methoxyflavone
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone
chryseriol
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-chromen-4-one
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-1-benzopyran-4-one
3'-methoxyapigenin
luteolin 3'-methyl ether
CHEBI:16514 ,
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-
brn 0295004
einecs 207-742-6
flavone, 4',5,7-trihydroxy-3'-methoxy-
3'-o-methyluteolin
5,7,4'-trihydroxy-3'-methoxyflavone
C04293
491-71-4
3'-o-methylluteolin
chrysoeriol
MLS001048958
smr000386981
NCGC00163527-01
nsc732318
2-(5-methoxy,7-dihydroxy-benzpyran-4-one
nsc-732318
cid_5280666
luteolin 3''-methyl ether
bdbm50241084
3''-methoxyapigenin
4'',5,7-trihydroxy-3''-methoxyflavone
chrysoeril
CHEMBL214321 ,
FT-0665034
LMPK12110799
AKOS004110683
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
HMS2271C08
unii-q813145m20
q813145m20 ,
ccris 9338
cresorol
3'-methoxy-4',5,7-trihydroxyflavone
chrysoriol
SCHEMBL293757
mfcd00016780
SCZVLDHREVKTSH-UHFFFAOYSA-N
DTXSID60197687 ,
sr-01000758948
SR-01000758948-3
2-(5-methoxy,4-hydroxyphenyl)5,7-dihydroxy-benzpyran-4-one
scoparol
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-1-benzopyran-4-one, 9ci
4',5,7-trihydroxy-3'-methoxy-flavone
BCP28924
chryseriol;3'-methoxyapigenin;luteolin 3'-methyl ether
Q2967432
HY-121471
CS-0082151
AMY36737
AC9701
3?-methoxy-4?,5,7-trihydroxyflavone
MS-24322
SY252786
3 inverted exclamation mark -methoxy-4 inverted exclamation mark ,5,7-trihydroxyflavone
A854414
EN300-17991263
dtxcid20120178

Research Excerpts

Overview

Chrysoeriol (CHE) is a natural flavone with potent XO inhibitory activity (IC) It is a flavonoid compound, and possesses anti-tumor activity in lung cancer, breast cancer and multiple myeloma; while whether it has anti-melanoma effects is still not known.

ExcerptReferenceRelevance
"Chrysoeriol (CHE) is a natural flavone with potent XO inhibitory activity (IC"( Investigation of the interaction between Chrysoeriol and xanthine oxidase using computational and in vitro approaches.
Chen, H; Han, C; Li, Y; Liu, Y; Lu, T; Tu, Y; Yang, C, 2021
)
1.61
"Chrysoeriol is a flavone found in medicinal herbs such as Chrysanthemi Indici Flos (the dried capitulum of Chrysanthemum indicum L.)."( Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling.
Bai, JX; Chen, YJ; Chou, JY; Fu, XQ; Li, AS; Li, JK; Wang, XQ; Wong, LY; Wu, JY; Wu, Y; Yin, CL; Yu, ZL, 2022
)
2.89
"Chrysoeriol is a flavonoid compound, and possesses anti-tumor activity in lung cancer, breast cancer and multiple myeloma; while whether it has anti-melanoma effects is still not known."( Inhibition of STAT3 signaling contributes to the anti-melanoma effects of chrysoeriol.
Chen, YJ; Ding, WJ; Dou, X; Fu, XQ; Li, SA; Liu, B; Liu, YX; Wang, XQ; Wu, JY; Wu, Y; Xu, BW; Yu, ZL, 2023
)
1.86
"Chrysoeriol is a flavone found in diverse dietary and medicinal herbs such as Lonicerae Japonicae Flos (the dried flower bud or newly bloomed flower of Lonicera japonica Thunb.). "( Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways.
Bai, JX; Bai, L; Chen, YJ; Chou, JY; Fu, XQ; Li, JK; Liu, YX; Wang, YP; Wu, JY; Wu, Y; Wu, ZZ; Yin, CL; Yu, ZL; Zhu, PL, 2020
)
3.44
"Chrysoeriol is a flavonoid with antioxidant and anti-inflammatory activities."( An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells.
Cha, BY; Nagai, K; Shi, WL; Teruya, T; Woo, JT; Yonezawa, T, 2009
)
1.38
"Chrysoeriol is a flavonoid compound found in several tropical medicinal plants. "( Chrysoeriol isolated from Eurya cilliata leaves protects MC3T3-E1 cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation.
Choi, EM; Kim, YH; Lee, YS, 2010
)
3.25
"Chrysoeriol is a flavonoid with antioxidant and anti-inflammatory activities. "( Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation.
Choi, DY; Kang, KW; Kim, MR; Kim, YG; Lee, JY; Woo, ER, 2005
)
3.21

Effects

Chrysoeriol has been shown to exert anti-inflammatory effects and inhibit STAT3 signaling in our previous studies.

ExcerptReferenceRelevance
"Chrysoeriol has been shown to exert anti-inflammatory effects and inhibit STAT3 signaling in our previous studies."( Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling.
Bai, JX; Chen, YJ; Chou, JY; Fu, XQ; Li, AS; Li, JK; Wang, XQ; Wong, LY; Wu, JY; Wu, Y; Yin, CL; Yu, ZL, 2022
)
2.89
"Chrysoeriol has been shown to restrain STAT3 signaling in an inflammation mouse model."( Inhibition of STAT3 signaling contributes to the anti-melanoma effects of chrysoeriol.
Chen, YJ; Ding, WJ; Dou, X; Fu, XQ; Li, SA; Liu, B; Liu, YX; Wang, XQ; Wu, JY; Wu, Y; Xu, BW; Yu, ZL, 2023
)
1.86

Treatment

Chrysoeriol treatment significantly (P < 0.05) reversed the cytotoxic effect of H₂O⁉. Chrysooriol pretreatment potently inhibited the release of NO in the cells treated with lipopolysaccharide.

ExcerptReferenceRelevance
"Chrysoeriol treatment significantly (P < 0.05) reversed the cytotoxic effect of H₂O₂ and increased collagen content, alkaline phosphatase activity and calcium deposition of osteoblasts in the presence of H₂O₂."( Chrysoeriol isolated from Eurya cilliata leaves protects MC3T3-E1 cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation.
Choi, EM; Kim, YH; Lee, YS, 2010
)
2.52
"Chrysoeriol pretreatment potently inhibited the release of NO in the cells treated with lipopolysaccharide (LPS), and Western blot and RT-PCR analyses revealed that chrysoeriol inhibited the LPS-induced inductions of iNOS gene."( Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation.
Choi, DY; Kang, KW; Kim, MR; Kim, YG; Lee, JY; Woo, ER, 2005
)
2.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monomethoxyflavoneAny methoxyflavone with a single methoxy substituent.
trihydroxyflavoneAny hydroxyflavone carrying three hydroxy groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Tricin biosynthesis315

Protein Targets (39)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency15.10140.007215.758889.3584AID588342
BRCA1Homo sapiens (human)Potency17.78280.89137.722525.1189AID624202
ATAD5 protein, partialHomo sapiens (human)Potency16.35350.004110.890331.5287AID504466; AID504467
USP1 protein, partialHomo sapiens (human)Potency0.19950.031637.5844354.8130AID743255
TDP1 proteinHomo sapiens (human)Potency20.59620.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency22.38720.180013.557439.8107AID1460
Smad3Homo sapiens (human)Potency25.11890.00527.809829.0929AID588855
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
hypothetical protein, conservedTrypanosoma bruceiPotency19.95260.223911.245135.4813AID624173
67.9K proteinVaccinia virusPotency10.00000.00018.4406100.0000AID720579; AID720580
pyruvate kinaseLeishmania mexicana mexicanaPotency15.84890.398113.744731.6228AID1721; AID1722
importin subunit beta-1 isoform 1Homo sapiens (human)Potency31.62285.804836.130665.1308AID540253; AID540263
DNA polymerase betaHomo sapiens (human)Potency39.81070.022421.010289.1251AID485314
flap endonuclease 1Homo sapiens (human)Potency35.48130.133725.412989.1251AID588795
snurportin-1Homo sapiens (human)Potency31.62285.804836.130665.1308AID540253; AID540263
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency17.78280.010323.856763.0957AID2662
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency79.43280.425612.059128.1838AID504891
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency31.62285.804816.996225.9290AID540253
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency11.22020.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency11.22020.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency11.22020.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency5.80480.004611.374133.4983AID624296
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency35.48130.00419.962528.1838AID2675
Endothelin receptor type BRattus norvegicus (Norway rat)Potency15.84890.562315.160931.6228AID1721
Endothelin-1 receptorRattus norvegicus (Norway rat)Potency15.84890.562315.160931.6228AID1721
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency26.85450.060110.745337.9330AID485367
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A1Homo sapiens (human)IC50 (µMol)0.09480.00791.24789.9000AID1452992; AID502474
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)1.11800.00011.774010.0000AID502473
Multidrug resistance-associated protein 1 Homo sapiens (human)IC50 (µMol)3.00000.00153.71109.6600AID427749
Mitogen-activated protein kinase 10Homo sapiens (human)IC50 (µMol)33.60000.00201.703510.0000AID1799639
Xanthine dehydrogenase/oxidaseBos taurus (cattle)IC50 (µMol)14.00000.00303.10159.8000AID338975
Mitogen-activated protein kinase 14Homo sapiens (human)IC50 (µMol)33.60000.00010.72667.8000AID1799639
Cytochrome P450 1B1Homo sapiens (human)IC50 (µMol)0.01980.00130.86969.9000AID1452991; AID502475
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)50.00002.41006.343310.0000AID427750
Aurora kinase BHomo sapiens (human)IC50 (µMol)3.98000.00030.96349.8000AID1801097
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glutathione S-transferase, partialHomo sapiens (human)EC50 (µMol)1.75001.512015.624446.8700AID1769
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glycogen synthase kinase-3 alphaHomo sapiens (human)AC503.64800.013529.7434171.7000AID463203
Catechol O-methyltransferaseRattus norvegicus (Norway rat)Km2.65502.38002.94754.1000AID1216717; AID1216719
Quinone oxidoreductaseMus musculus (house mouse)CD11.70000.20002.74219.8000AID356395
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (235)

Processvia Protein(s)Taxonomy
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
leukotriene metabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
response to xenobiotic stimulusMultidrug resistance-associated protein 1 Homo sapiens (human)
cobalamin transportMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid biosynthetic processMultidrug resistance-associated protein 1 Homo sapiens (human)
cellular response to oxidative stressMultidrug resistance-associated protein 1 Homo sapiens (human)
heme catabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transportMultidrug resistance-associated protein 1 Homo sapiens (human)
phospholipid translocationMultidrug resistance-associated protein 1 Homo sapiens (human)
positive regulation of inflammatory responseMultidrug resistance-associated protein 1 Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
cell chemotaxisMultidrug resistance-associated protein 1 Homo sapiens (human)
transepithelial transportMultidrug resistance-associated protein 1 Homo sapiens (human)
cyclic nucleotide transportMultidrug resistance-associated protein 1 Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 1 Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid translocationMultidrug resistance-associated protein 1 Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 1 Homo sapiens (human)
cellular response to amyloid-betaMultidrug resistance-associated protein 1 Homo sapiens (human)
carboxylic acid transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transport across blood-brain barrierMultidrug resistance-associated protein 1 Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
protein phosphorylationMitogen-activated protein kinase 10Homo sapiens (human)
signal transductionMitogen-activated protein kinase 10Homo sapiens (human)
JNK cascadeMitogen-activated protein kinase 10Homo sapiens (human)
response to light stimulusMitogen-activated protein kinase 10Homo sapiens (human)
Fc-epsilon receptor signaling pathwayMitogen-activated protein kinase 10Homo sapiens (human)
regulation of circadian rhythmMitogen-activated protein kinase 10Homo sapiens (human)
rhythmic processMitogen-activated protein kinase 10Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 10Homo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseBos taurus (cattle)
positive regulation of blood vessel endothelial cell migrationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 14Homo sapiens (human)
DNA damage checkpoint signalingMitogen-activated protein kinase 14Homo sapiens (human)
cell morphogenesisMitogen-activated protein kinase 14Homo sapiens (human)
cartilage condensationMitogen-activated protein kinase 14Homo sapiens (human)
angiogenesisMitogen-activated protein kinase 14Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
placenta developmentMitogen-activated protein kinase 14Homo sapiens (human)
response to dietary excessMitogen-activated protein kinase 14Homo sapiens (human)
chondrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusMitogen-activated protein kinase 14Homo sapiens (human)
glucose metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
apoptotic processMitogen-activated protein kinase 14Homo sapiens (human)
chemotaxisMitogen-activated protein kinase 14Homo sapiens (human)
signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
skeletal muscle tissue developmentMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myotube differentiationMitogen-activated protein kinase 14Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 14Homo sapiens (human)
fatty acid oxidationMitogen-activated protein kinase 14Homo sapiens (human)
platelet activationMitogen-activated protein kinase 14Homo sapiens (human)
regulation of ossificationMitogen-activated protein kinase 14Homo sapiens (human)
osteoclast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 14Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
response to muramyl dipeptideMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 14Homo sapiens (human)
response to insulinMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of hippo signalingMitogen-activated protein kinase 14Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusMitogen-activated protein kinase 14Homo sapiens (human)
response to muscle stretchMitogen-activated protein kinase 14Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of protein import into nucleusMitogen-activated protein kinase 14Homo sapiens (human)
signal transduction in response to DNA damageMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
glucose importMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of glucose importMitogen-activated protein kinase 14Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
stem cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
striated muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 14Homo sapiens (human)
bone developmentMitogen-activated protein kinase 14Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipoteichoic acidMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to tumor necrosis factorMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to ionizing radiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of brown fat cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 14Homo sapiens (human)
stress-induced premature senescenceMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 14Homo sapiens (human)
regulation of synaptic membrane adhesionMitogen-activated protein kinase 14Homo sapiens (human)
regulation of cytokine production involved in inflammatory responseMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast fusionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1B1Homo sapiens (human)
angiogenesisCytochrome P450 1B1Homo sapiens (human)
trabecular meshwork developmentCytochrome P450 1B1Homo sapiens (human)
DNA modificationCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1B1Homo sapiens (human)
nitric oxide biosynthetic processCytochrome P450 1B1Homo sapiens (human)
cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to nutrientCytochrome P450 1B1Homo sapiens (human)
steroid metabolic processCytochrome P450 1B1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell population proliferationCytochrome P450 1B1Homo sapiens (human)
male gonad developmentCytochrome P450 1B1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressCytochrome P450 1B1Homo sapiens (human)
toxin metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionCytochrome P450 1B1Homo sapiens (human)
positive regulation of smooth muscle cell migrationCytochrome P450 1B1Homo sapiens (human)
sterol metabolic processCytochrome P450 1B1Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 1B1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
collagen fibril organizationCytochrome P450 1B1Homo sapiens (human)
adrenal gland developmentCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell migrationCytochrome P450 1B1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityCytochrome P450 1B1Homo sapiens (human)
response to follicle-stimulating hormoneCytochrome P450 1B1Homo sapiens (human)
response to estradiolCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinCytochrome P450 1B1Homo sapiens (human)
benzene-containing compound metabolic processCytochrome P450 1B1Homo sapiens (human)
retinol metabolic processCytochrome P450 1B1Homo sapiens (human)
retinal metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of apoptotic processCytochrome P450 1B1Homo sapiens (human)
blood vessel endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
estrous cycleCytochrome P450 1B1Homo sapiens (human)
positive regulation of translationCytochrome P450 1B1Homo sapiens (human)
positive regulation of angiogenesisCytochrome P450 1B1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCytochrome P450 1B1Homo sapiens (human)
membrane lipid catabolic processCytochrome P450 1B1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1B1Homo sapiens (human)
blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
retinal blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
ganglion developmentCytochrome P450 1B1Homo sapiens (human)
cellular response to hydrogen peroxideCytochrome P450 1B1Homo sapiens (human)
cellular response to cAMPCytochrome P450 1B1Homo sapiens (human)
cellular response to tumor necrosis factorCytochrome P450 1B1Homo sapiens (human)
cellular response to luteinizing hormone stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to cortisol stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to progesterone stimulusCytochrome P450 1B1Homo sapiens (human)
response to dexamethasoneCytochrome P450 1B1Homo sapiens (human)
endothelial cell-cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to indole-3-methanolCytochrome P450 1B1Homo sapiens (human)
cellular response to toxic substanceCytochrome P450 1B1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1B1Homo sapiens (human)
regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of DNA biosynthetic processCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIAurora kinase BHomo sapiens (human)
mitotic cell cycleAurora kinase BHomo sapiens (human)
mitotic cytokinesisAurora kinase BHomo sapiens (human)
negative regulation of B cell apoptotic processAurora kinase BHomo sapiens (human)
protein phosphorylationAurora kinase BHomo sapiens (human)
spindle organizationAurora kinase BHomo sapiens (human)
attachment of spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
abscissionAurora kinase BHomo sapiens (human)
negative regulation of protein bindingAurora kinase BHomo sapiens (human)
positive regulation of telomere maintenance via telomeraseAurora kinase BHomo sapiens (human)
negative regulation of cytokinesisAurora kinase BHomo sapiens (human)
positive regulation of cytokinesisAurora kinase BHomo sapiens (human)
protein localization to kinetochoreAurora kinase BHomo sapiens (human)
cellular response to UVAurora kinase BHomo sapiens (human)
cleavage furrow formationAurora kinase BHomo sapiens (human)
post-translational protein modificationAurora kinase BHomo sapiens (human)
cell cycle G2/M phase transitionAurora kinase BHomo sapiens (human)
mitotic cytokinesis checkpoint signalingAurora kinase BHomo sapiens (human)
negative regulation of innate immune responseAurora kinase BHomo sapiens (human)
protein autophosphorylationAurora kinase BHomo sapiens (human)
mitotic spindle midzone assemblyAurora kinase BHomo sapiens (human)
positive regulation of telomerase activityAurora kinase BHomo sapiens (human)
regulation of chromosome segregationAurora kinase BHomo sapiens (human)
positive regulation of mitotic sister chromatid segregationAurora kinase BHomo sapiens (human)
positive regulation of mitotic cell cycle spindle assembly checkpointAurora kinase BHomo sapiens (human)
mitotic spindle assemblyAurora kinase BHomo sapiens (human)
negative regulation of cGAS/STING signaling pathwayAurora kinase BHomo sapiens (human)
regulation of signal transduction by p53 class mediatorAurora kinase BHomo sapiens (human)
positive regulation of mitotic sister chromatid separationAurora kinase BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
positive regulation of mitotic cytokinesisAurora kinase BHomo sapiens (human)
positive regulation of telomere cappingAurora kinase BHomo sapiens (human)
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
mitotic spindle organizationAurora kinase BHomo sapiens (human)
regulation of cytokinesisAurora kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (58)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type vitamin B12 transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled lipid transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
carboxylic acid transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
JUN kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein bindingMitogen-activated protein kinase 10Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 10Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine oxidase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
iron ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdenum ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
protein homodimerization activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
FAD bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
protein serine/threonine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 14Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 14Homo sapiens (human)
mitogen-activated protein kinase p38 bindingMitogen-activated protein kinase 14Homo sapiens (human)
NFAT protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
monooxygenase activityCytochrome P450 1B1Homo sapiens (human)
iron ion bindingCytochrome P450 1B1Homo sapiens (human)
protein bindingCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
heme bindingCytochrome P450 1B1Homo sapiens (human)
aromatase activityCytochrome P450 1B1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1B1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
protein serine/threonine kinase activityAurora kinase BHomo sapiens (human)
protein serine/threonine kinase activityAurora kinase BHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityAurora kinase BHomo sapiens (human)
protein bindingAurora kinase BHomo sapiens (human)
ATP bindingAurora kinase BHomo sapiens (human)
kinase bindingAurora kinase BHomo sapiens (human)
protein serine kinase activityAurora kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (38)

Processvia Protein(s)Taxonomy
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
basal plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
lateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
extracellular exosomeMultidrug resistance-associated protein 1 Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 10Homo sapiens (human)
plasma membraneMitogen-activated protein kinase 10Homo sapiens (human)
nucleusMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseBos taurus (cattle)
peroxisomeXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine dehydrogenase complexXanthine dehydrogenase/oxidaseBos taurus (cattle)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
spindle poleMitogen-activated protein kinase 14Homo sapiens (human)
extracellular regionMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
nuclear speckMitogen-activated protein kinase 14Homo sapiens (human)
secretory granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
glutamatergic synapseMitogen-activated protein kinase 14Homo sapiens (human)
ficolin-1-rich granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1B1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1B1Homo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
kinetochoreAurora kinase BHomo sapiens (human)
condensed chromosome, centromeric regionAurora kinase BHomo sapiens (human)
nucleusAurora kinase BHomo sapiens (human)
nucleoplasmAurora kinase BHomo sapiens (human)
spindleAurora kinase BHomo sapiens (human)
cytosolAurora kinase BHomo sapiens (human)
chromocenterAurora kinase BHomo sapiens (human)
microtubule cytoskeletonAurora kinase BHomo sapiens (human)
midbodyAurora kinase BHomo sapiens (human)
chromosome passenger complexAurora kinase BHomo sapiens (human)
mitotic spindle poleAurora kinase BHomo sapiens (human)
mitotic spindle midzoneAurora kinase BHomo sapiens (human)
kinetochoreAurora kinase BHomo sapiens (human)
spindle pole centrosomeAurora kinase BHomo sapiens (human)
spindle microtubuleAurora kinase BHomo sapiens (human)
spindle midzoneAurora kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (160)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID332705Activation of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID356394Chemoprevention index, ratio of IC50 for mouse Hepa-1c1c7 cells to drug level required to double NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells2003Journal of natural products, Sep, Volume: 66, Issue:9
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria.
AID1236855Retention time of the compound by HPLC-SPE-NMR analysis2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID439371Agonist activity at human PPARalpha expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1162630Toxicity against human MDA-MB-231 cells co-cultured with human THP1 cells assessed as cell death at 25 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162632Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 protein expression at 6.25 to 50 uM pre-incubated before PMA stimulation by SDS-PAGE gelatin zymography2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1239715Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID398503Cytotoxicity against human DU145 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID765679Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of superoxide anion radical-induced lucigenin oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID1216694Drug metabolism in Sprague-Dawley rat small intestine homogenate treated with luteolin at 20 uM after 20 to 60 mins2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID338975Inhibition of cow milk xanthine oxidase
AID1668637Inhibition of human liver FBP1 at 200 uM incubated for 5 mins by fluorescence method relative to control2020Journal of natural products, 05-22, Volume: 83, Issue:5
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
AID398501Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1162601Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 12.5 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID398497Cytotoxicity against mouse P388 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398507Antimicrobial activity against Micrococcus luteus2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1216697Drug metabolism in Sprague-Dawley rat erythrocytes homogenate treated with luteolin at 20 uM after 20 to 60 mins2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216719Activity of COMT in Sprague-Dawley rat erythrocytes homogenate treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216675Half life in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162203Inhibition of NO production in LPS-stimulated mouse RAW264.7 cells pre-incubated for 2 hrs before LPS stimulation for 24 hrs by Griess assay method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
New guaiane sesquiterpenes from Artemisia rupestris and their inhibitory effects on nitric oxide production.
AID1216680Drug excretion in Sprague-Dawley rat urine treated with luteolin at 6.5 mg/kg, iv after 24 hrs2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID379054Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID1216677Volume of distribution in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216717Activity of COMT in Sprague-Dawley rat lung treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID398509Antimicrobial activity against Cryptococcus neoformans2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID270127Albumin level in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID1216724Activity of COMT in Sprague-Dawley rat kidney homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216676Clearance in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162628Toxicity against human THP1 cells assessed as cell death at 25 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID356393Inhibition of mouse Hepa-1c1c7 cells by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria.
AID1216685Drug metabolism in Sprague-Dawley rat liver homogenate treated with luteolin at 20 uM after 20 to 60 mins2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216706Drug metabolism in Sprague-Dawley rat lung homogenate treated with luteolin at 20 uM after 20 to 60 mins in presence of COMT inhibitor entacapone2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID398502Cytotoxicity against human KM20L2 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398506Antimicrobial activity against Streptococcus pneumoniae2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1216712Drug metabolism in Sprague-Dawley rat erythrocytes homogenate treated with luteolin at 20 uM after 20 to 60 mins in presence of COMT inhibitor entacapone2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162614Cytotoxicity against non-stimulated human MDA-MB-231 cells assessed as induction of cell death up to 25 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162629Toxicity against human THP1 cells co-cultured with human MDA-MB-231 cells assessed as cell death at 25 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216723Activity of COMT in Sprague-Dawley rat liver homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162619Induction of cell cycle arrest in un-stimulated human MDA-MB-231 cells assessed as accumulation at G2/M phase at 25 uM after 48 hrs by propidium iodide staining based flow cytometry2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216709Drug metabolism in Sprague-Dawley rat small intestine homogenate treated with luteolin at 20 uM after 20 to 60 mins in presence of COMT inhibitor entacapone2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID357365Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2001Journal of natural products, Aug, Volume: 64, Issue:8
Samioside, a new phenylethanoid glycoside with free-radical scavenging and antimicrobial activities from Phlomis samia.
AID1216672AUC (0 to infinity) in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID398512Antimicrobial activity against Staphylococcus aureus2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1239716Potency index, ratio of anti-platelet activity for aspirin to test compound in rat platelet rich plasma2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID270126Total protein level in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID1370496Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitro-phenyl-alpha-D-glucopyranoside as substrate at 200 uM preincubated with enzyme followed by substrate addition measured after 10 mins for every 2.5 to 5 mins relative to control2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
AID1216674Mean residence time (0 to infinity) in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID270125Cholesterol level in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID334449Chemopreventive activity in Syrian hamster embryo cells assessed as pmol of (+)-anti-benzo(a)pyrene-7,8-diol-9,10-epoxide -dGuo adduct per mg of DNA at 10 ug/ml by [35S]phosphorothote post-labeling-HPLC1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID334447Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of [3H]benzo(a)pyrene-DNA binding at 10 ug/ml by [35S]phosphorothote post-labeling-HPLC1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID1162621Induction of cell cycle arrest in PMA-stimulated human MDA-MB-231 cells assessed as accumulation at G1 phase at 25 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 52%)2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162607Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in COX2 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID469266Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method2009Journal of natural products, Sep, Volume: 72, Issue:9
Triterpenoids and flavonoids from celery (Apium graveolens).
AID334444Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of metabolism of [3H]benzo(a)pyrene to water-soluble metabolites after 24 hrs at 20 ug/ml relative to control1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID379055Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID334445Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of metabolism of [3H]benzo(a)pyrene to water-soluble metabolites after 24 hrs at 10 ug/ml relative to control1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID356392Inhibition of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in a mouse mammary gland culture at 10 ug/mL2003Journal of natural products, Sep, Volume: 66, Issue:9
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria.
AID1216703Drug metabolism in Sprague-Dawley rat kidney homogenate treated with luteolin at 20 uM after 20 to 60 mins in presence of COMT inhibitor entacapone2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1525197Transrepression of GAL4-fused RXRalpha LBD (unknown origin) expressed in 293T cells assessed as inhibition of 9-cis-RA-induced transcription measured after 12 hrs by dual-luciferase reporter gene assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Cytotoxic Components from Hypericum elodeoides Targeting RXRα and Inducing HeLa Cell Apoptosis through Caspase-8 Activation and PARP Cleavage.
AID1216691Drug metabolism in Sprague-Dawley rat lung homogenate treated with luteolin at 20 uM after 20 to 60 mins2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162615Cytotoxicity against PMA-stimulated human MDA-MB-231 cells assessed as induction of cell death up to 25 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216678Cmax in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216671AUC (0 to t) in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216700Drug metabolism in Sprague-Dawley rat liver homogenate treated with luteolin at 20 uM after 20 to 60 mins in presence of COMT inhibitor entacapone2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1631834Antitrypanosomal activity against Trypanosoma brucei brucei Lister 427 bloodstream forms after 72 hrs by resazurin-based assay2016Journal of medicinal chemistry, 08-25, Volume: 59, Issue:16
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
AID398511Antimicrobial activity against Stenotrophomonas maltophilia2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1216726Activity of COMT in Sprague-Dawley rat small intestine homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID270119Alanine aminotransferase activity in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID427750Inhibition of MRP22009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives.
AID1162600Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 6.25 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID398498Cytotoxicity against human BxPC3 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID765677Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of H2O2-induced oxidation of amplex red incubated for 5 mins prior to PMA challenge by fluorescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID1162624Inhibition of cell migration of PMA-stimulated human MDA-MB-231 cells2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID439372Agonist activity at human PPARalpha expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 40 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1216725Activity of COMT in Sprague-Dawley rat lung homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID765674Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of HOCl-induced oxidation of APF after 6 mins by fluorescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID1216731Ratio of Vmax(app) to Km(app) for COMT in Sprague-Dawley rat small intestine homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162617Cytotoxicity against PMA-stimulated human MDA-MB-231 cells assessed as induction of cell death at 50 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID356395Induction of NADPH:quinone reductase in mouse Hepa-1c1c7 cells assessed as drug level required to double enzyme activity by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria.
AID736341Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as beta-galactosidase activity at 50 uM measured after 48 hrs relative to vehicle control2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
AID1162606Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 50 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID334448Chemopreventive activity in Syrian hamster embryo cells assessed as pmol of [3H]benzo(a)pyrene binding per mg of DNA at 10 ug/ml by [35S]phosphorothote post-labeling-HPLC1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID1162616Cytotoxicity against non-stimulated human MDA-MB-231 cells assessed as induction of cell death at 50 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216673Mean residence time (0 to t) in Sprague-Dawley rat treated with luteolin at 6.5 mg/kg, iv2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID502475Inhibition of human CYP1B1 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID294154Inhibition of diphenolase activity of mushroom tyrosinase at 0.083 mM2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.
AID1216729Ratio of Vmax(app) to Km(app) for COMT in Sprague-Dawley rat kidney homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216720Stability in Sprague-Dawley rat liver microsomes at 10 uM after 10 to 30 mins by HPLC analysis2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216715Activity of COMT in Sprague-Dawley rat liver homogenate treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID332707Activation of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID439367Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 5 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1452991Inhibition of recombinant human CYP1B1 expressed in supersomes using ethoxyresorufin as substrate preincubated for 5 mins followed by substrate addition in presence of NADPH by fluorimetric analysis2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID270121Gamma-glutamyl transferase activity in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID1216730Ratio of Vmax(app) to Km(app) for COMT in Sprague-Dawley rat lung treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162623Induction of cell cycle arrest in PMA-stimulated human MDA-MB-231 cells assessed as accumulation at G2/M phase at 25 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 19%)2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1452992Inhibition of recombinant human CYP1A1 expressed in supersomes using ethoxyresorufin as substrate preincubated for 5 mins followed by substrate addition in presence of NADPH by fluorimetric analysis2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1162609Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 12.5 uM by quantitative RT-PCR method2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162599Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 3.125 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID270122Glucose level in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID400608Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID1216718Activity of COMT in Sprague-Dawley rat small intestine homogenate treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1525196Transrepression of GAL4-fused RXRalpha LBD (unknown origin) expressed in 293T cells assessed as inhibition of 9-cis-RA-induced transcription at 50 uM measured after 12 hrs by dual-luciferase reporter gene assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Cytotoxic Components from Hypericum elodeoides Targeting RXRα and Inducing HeLa Cell Apoptosis through Caspase-8 Activation and PARP Cleavage.
AID1162622Induction of cell cycle arrest in PMA-stimulated human MDA-MB-231 cells assessed as accumulation at S phase at 25 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 29%)2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162604Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 12.5 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162602Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162603Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 50 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216716Activity of COMT in Sprague-Dawley rat kidney homogenate treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID439368Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1216683Drug recovery in Sprague-Dawley rat urine assessed as retention time treated with luteolin at 6.5 mg/kg, iv by reverse-phase HPLC method2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1162620Toxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID765681Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID270124Triglyceride level in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID1435548Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 10 mg/ml after 24 hrs by disk diffusion method2016Journal of natural products, 11-23, Volume: 79, Issue:11
Phenanthrenes from Juncus inflexus with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus.
AID1216682Drug excretion in Sprague-Dawley rat urine treated with luteolin at 6.5 mg/kg, iv after 24 hrs co-treated with COMT inhibitor entacapone2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1063902Inhibition of 5-LOX-mediated LTB4 production in human neutrophils using arachidonic acid as substrate at 40 uM preincubated for 10 mins followed by substrate addition measured after 8 mins by enzyme immunoassay relative to control2014European journal of medicinal chemistry, Jan-24, Volume: 72Inhibition of LOX by flavonoids: a structure-activity relationship study.
AID1216732Ratio of Vmax(app) to Km(app) for COMT in Sprague-Dawley rat erythrocytes homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID398500Cytotoxicity against human SF268 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID502473Inhibition of human CYP1A2 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID1162608Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID427749Inhibition of MRP12009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives.
AID736345Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as beta-galactosidase activity at 25 uM measured after 48 hrs relative to vehicle control2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
AID1162204Cytotoxicity against mouse RAW264.7 cells at 0.01 to 100 uM after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
New guaiane sesquiterpenes from Artemisia rupestris and their inhibitory effects on nitric oxide production.
AID270120Aspartate aminotransferase activity in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID1162618Induction of cell cycle arrest in PMA-stimulated human MDA-MB-231 cells assessed as accumulation at G2/M phase at 25 uM after 48 hrs by propidium iodide staining based flow cytometry2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162627Induction apoptosis in PMA-stimulated human MDA-MB-231 cells assessed as mitochondrial disruption up to 50 uM uM after 48 hrs by JC1 staining based fluorescence assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1162625Inhibition of cell invasion of PMA-stimulated human MDA-MB-231 cells2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216727Activity of COMT in Sprague-Dawley rat erythrocytes homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1370495Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitro-phenyl-alpha-D-glucopyranoside as substrate preincubated with enzyme followed by substrate addition measured after 10 mins for every 2.5 to 5 mins2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
AID398508Antimicrobial activity against Enterobacter cloacae2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1385462Cytotoxicity against HUVEC at 1 ug/ml after 24 hrs by MTT assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
NF-κB and Angiogenesis Inhibitors from the Aerial Parts of Chresta martii.
AID398510Antimicrobial activity against Candida albicans2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID1162595Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID270123Total bilirubin level in Sprague-Dawley rat serum at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Hepatoprotective activity of Schouwia thebica webb.
AID398499Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID765682Cytotoxicity against human neutrophils assessed as cell viability at 100 uM after 1 hr by trypan blue exclusion assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID502474Inhibition of human CYP1A1 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID1162605Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1216728Ratio of Vmax(app) to Km(app) for COMT in Sprague-Dawley rat liver homogenate assessed per mg protein treated with luteolin up to 10 mins by Michaelis-Menten equation2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID1216688Drug metabolism in Sprague-Dawley rat kidney homogenate treated with luteolin at 20 uM after 20 to 60 mins2011Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 39, Issue:4
Role of catechol-O-methyltransferase in the disposition of luteolin in rats.
AID334446Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of metabolism of [3H]benzo(a)pyrene to water-soluble metabolites after 24 hrs at 5 ug/ml relative to control1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID1801097Aurora B Kinase Assay from Article 10.1111/cbdd.12445: \\Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.\\2015Chemical biology & drug design, May, Volume: 85, Issue:5
Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
AID1799639Kinase Assay from Article 10.1002/cbic.201000487: \\Biological evaluation and structural determinants of p38u00CEu00B1 mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.\\2010Chembiochem : a European journal of chemical biology, Dec-10, Volume: 11, Issue:18
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (99)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (4.04)18.2507
2000's34 (34.34)29.6817
2010's45 (45.45)24.3611
2020's16 (16.16)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.65 (24.57)
Research Supply Index4.65 (2.92)
Research Growth Index5.53 (4.65)
Search Engine Demand Index59.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other103 (99.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]